Peritoneal dialysis guidelines 2019 part 1 (Position paper of the Japanese society for dialysis therapy)
Y Ito, M Ryuzaki, H Sugiyama, T Tomo… - Renal Replacement …, 2021 - Springer
Approximately 10 years have passed since the Peritoneal Dialysis Guidelines were
formulated in 2009. Much evidence has been reported during the succeeding years, which …
formulated in 2009. Much evidence has been reported during the succeeding years, which …
[HTML][HTML] Efficacy of triple diuretic treatment in continuous ambulatory peritoneal dialysis patients: A randomized controlled trial
R Witoon, S Yongsiri, P Buranaburidej… - Kidney Research and …, 2019 - ncbi.nlm.nih.gov
Background The efficacy of combined diuretic treatment in patients undergoing continuous
ambulatory peritoneal dialysis (CAPD) is not known. Methods In a single-center, double …
ambulatory peritoneal dialysis (CAPD) is not known. Methods In a single-center, double …
Comparison of the effects of tolvaptan and furosemide on renal water and sodium excretion in patients with heart failure and advanced chronic kidney disease: a …
N Tominaga, K Kida, T Inomata, N Sato, T Izumi… - Clinical and …, 2018 - Springer
Background Tolvaptan (TLV) is known to increase electrolyte-free water clearance.
However, TLV actions on renal electrolytes including urine sodium (uNa) excretion and its …
However, TLV actions on renal electrolytes including urine sodium (uNa) excretion and its …
A Case of Hepatitis E Virus Infection: One of Differential Diagnosis of Liver Injury in Patients Undergoing Peritoneal Dialysis
T Yan, Y Sakai, K Terada, S Okano… - … Case Reports Journal, 2022 - Taylor & Francis
Background There are numerous causes of liver function disorder in patients undergoing
peritoneal dialysis (PD). Infection with the Hepatitis E virus (HEV) is a rare cause of liver …
peritoneal dialysis (PD). Infection with the Hepatitis E virus (HEV) is a rare cause of liver …